Cargando…
TCR-engineered T cell therapy in solid tumors: State of the art and perspectives
T cell engineering has changed the landscape of cancer immunotherapy. Chimeric antigen receptor T cells have demonstrated a remarkable efficacy in the treatment of B cell malignancies in hematology. However, their clinical impact on solid tumors has been modest so far. T cells expressing an engineer...
Autores principales: | Baulu, Estelle, Gardet, Célia, Chuvin, Nicolas, Depil, Stéphane |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Association for the Advancement of Science
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9931212/ https://www.ncbi.nlm.nih.gov/pubmed/36791198 http://dx.doi.org/10.1126/sciadv.adf3700 |
Ejemplares similares
-
Identification of shared tumor epitopes from endogenous retroviruses inducing high-avidity cytotoxic T cells for cancer immunotherapy
por: Bonaventura, Paola, et al.
Publicado: (2022) -
Harnessing T cell exhaustion and trogocytosis to isolate patient-derived tumor-specific TCR
por: Manfredi, Francesco, et al.
Publicado: (2023) -
DGKα/ζ inhibition lowers the TCR affinity threshold and potentiates antitumor immunity
por: Kureshi, Rakeeb, et al.
Publicado: (2023) -
The magnitude of LFA-1/ICAM-1 forces fine-tune TCR-triggered T cell activation
por: Ma, Victor Pui-Yan, et al.
Publicado: (2022) -
Fluoride permeation mechanism of the Fluc channel in liposomes revealed by solid-state NMR
por: Zhang, Jin, et al.
Publicado: (2023)